Ascelia Pharma AB (publ) (STO:ACE)

Ascelia Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57.3	75.26	21.86	149.56	261.6	184.69
Cash & Short-Term Investments	57.3	75.26	21.86	149.56	261.6	184.69
Cash Growth	115.88%	244.34%	-85.39%	-42.83%	41.64%	0.25%
Other Receivables	3.91	6.1	2.99	5.16	5.87	2.83
Receivables	3.91	6.1	2.99	5.16	5.87	2.83
Prepaid Expenses	1.52	0.61	0.66	0.79	0.96	0.53
Other Current Assets	1.76	1.75	3.43	5.36	6.18	8.28
Total Current Assets	64.49	83.72	28.94	160.87	274.61	196.32
Property, Plant & Equipment	1.42	0.12	1.06	0.63	1.82	1.99
Other Intangible Assets	57.07	57.08	57.07	57.07	57.06	57.06
Other Long-Term Assets	-	-	-0	0	-	-
Total Assets	122.98	140.92	87.07	218.57	333.49	255.37
Accounts Payable	4.98	4.73	1.53	15.88	6.15	3.88
Accrued Expenses	14.38	12.73	8.52	19.66	16.34	12.98
Short-Term Debt	25.78	25.23	-	-	-	-
Current Portion of Leases	0.77	0.17	0.88	0.29	1.1	0.82
Current Income Taxes Payable	-	-	-	-	0.01	-
Other Current Liabilities	18.56	19.11	1.64	1.69	1.51	0.67
Total Current Liabilities	64.47	61.98	12.57	37.52	25.11	18.36
Long-Term Leases	0.69	-	0.18	0.19	0.55	0.96
Other Long-Term Liabilities	-	-	-	-0	-	-
Total Liabilities	65.16	61.98	12.74	37.71	25.66	19.32
Common Stock	97.19	97.19	34.87	34.87	34.58	28.7
Additional Paid-In Capital	721.75	721.75	678.75	678.75	678.83	493.73
Retained Earnings	-762.22	-740.97	-639.96	-533.73	-405.83	-286.49
Comprehensive Income & Other	1.1	0.97	0.67	0.97	0.25	0.12
Shareholders' Equity	57.82	78.94	74.33	180.86	307.83	236.06
Total Liabilities & Equity	122.98	140.92	87.07	218.57	333.49	255.37
Total Debt	27.24	25.4	1.06	0.48	1.66	1.78
Net Cash (Debt)	30.06	49.86	20.8	149.07	259.94	182.91
Net Cash Growth	288.42%	139.76%	-86.05%	-42.65%	42.12%	-0.60%
Net Cash Per Share	0.43	0.92	0.62	4.28	7.89	6.96
Filing Date Shares Outstanding	94.49	96.11	33.76	33.67	33.67	28.19
Total Common Shares Outstanding	94.49	96.11	33.76	33.67	33.67	28.19
Working Capital	0.02	21.74	16.37	123.35	249.51	177.96
Book Value Per Share	0.61	0.82	2.20	5.37	9.14	8.37
Tangible Book Value	0.75	21.87	17.25	123.79	250.77	179
Tangible Book Value Per Share	0.01	0.23	0.51	3.68	7.45	6.35
Machinery	-	0.6	0.6	0.6	0.6	0.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.